+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

In-vitro Transcription Templates Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020-2030

  • ID: 5367262
  • Report
  • May 2021
  • Region: Global
  • 233 pages
  • Transparency Market Research

FEATURED COMPANIES

  • Cytiva (Danaher)
  • Enzo Life Sciences, Inc.
  • Enzynomics Co. Ltd.
  • Lucigen Corporation
  • New England Biolabs
  • Promega Corporation
This report on the global in-vitro transcription templates market studies past as well as current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2020 to 2030. The report provides revenue of the global in-vitro transcription templates market for the period of 2018-2030, considering 2019 as the base year and 2030 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the global in-vitro transcription templates market during the forecast period.



The report has been prepared after primary and secondary researches. Primary research involved bulk of research efforts, wherein analysts carried out interviews with industry leaders and opinion makers. Extensive secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the global in-vitro transcription templates market.

Secondary research also included Internet sources, statistical data from government agencies, websites, company presentations, sales data, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various phenomenon in the global in-vitro transcription templates market.

The report includes an elaborate executive summary along with a snapshot of the growth behavior of various segments included in the scope of the study. Furthermore, the report sheds light on the changing competitive dynamics in the global in-vitro transcription templates market. These indices serve as valuable tools for existing market players as well as for entities interested in entering the global in-vitro transcription templates market.

The report delves into the competitive landscape of the global in-vitro transcription templates market. Key players operating in the global in-vitro transcription templates market have been identified, and each one of these has been profiled for distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players in the global in-vitro transcription templates market that have been profiled in this report.

Key Questions Answered in the Report
  • What is the scope of growth for product companies in the global in-vitro transcription templates market?
  • What will be the Y-o-Y growth of the global in-vitro transcription templates market between 2020 and 2030?
  • What is the influence of changing trends in technologies on the global in-vitro transcription templates market?
Will North America continue to be the most profitable market for in-vitro transcription templates
  • Which factors are anticipated to hamper the global in-vitro transcription templates market during the forecast period?
  • Which are the leading companies in the global in-vitro transcription templates market?
Research Methodology

A unique methodology has been utilized by the publisher to conduct comprehensive research on the growth of the global in-vitro transcription templates market and arrive at conclusions on its growth prospects. This research methodology is a combination of primary and secondary research, which helps analysts warrant the accuracy and reliability of the drawn conclusions.

Secondary research sources referred to by analysts during the production of the global in-vitro transcription templates market report include statistics from company annual reports, SEC filings, company websites, investor presentations, regulatory databases, government publications, and industry white papers. Analysts have also interviewed senior managers, product portfolio managers, CEOs, VPs, and market intelligence managers, who contributed to the production of the publisher’s study on the in-vitro transcription templates market as primary methods.

These primary research respondents have provided exclusive information during interviews, which serves as a validation from the in-vitro transcription templates market leaders. Access to an extensive internal repository and external proprietary databases enabled this report to address specific details and questions about the global in-vitro transcription templates market with accuracy. The study also uses the top-down approach to assess the revenue of each segment and the bottom-up approach to counter-validate them. This has helped in reaching the publisher’s estimates on future prospects of the global in-vitro transcription templates more reliably and accurately.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Cytiva (Danaher)
  • Enzo Life Sciences, Inc.
  • Enzynomics Co. Ltd.
  • Lucigen Corporation
  • New England Biolabs
  • Promega Corporation
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global In-vitro Transcription Templates Market

4. Market Overview
4.1. Introduction
4.1.1. Disease Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global In-vitro Transcription Templates Market Analysis and Forecast, 2017-2031
4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights
5.1. Technological Advancements
5.2. Major Research Institutes Involved
5.3. Disease Prevalence & Incidence Rate globally with key countries
5.4. Number of mRNA Templates utilized Per Year
5.5. Analysis of Purchase Criteria (vaccine/therapeutics/research)
5.5.1. Overview of Purchase Criteria
5.5.2. mRNA Size Needs
5.5.3. Synthesis Scale Needs
5.5.4. Modified Bases Needs
5.5.5. cGMP/21 CFR part 11 certification requirement assessment
5.6. COVID-19 Pandemic Impact on Industry (value chain and short / mid /long term impact)

6. Global In-vitro Transcription Templates Market Analysis and Forecast, by Disease
6.1. Introduction & Definition
6.1.1. Key Findings / Developments
6.2. Global In-vitro Transcription Templates Market Value Forecast, by Disease, 2017-2031
6.2.1. Cancer
6.2.1.1. Solid Tumors
6.2.1.2. Colorectal Cancer
6.2.1.3. NSCLC
6.2.1.4. Melanoma
6.2.1.5. Leukemia
6.2.1.6. Prostate Cancer
6.2.1.7. Others
6.2.2. Infectious Diseases
6.2.2.1. Influenza
6.2.2.2. COVID-19
6.2.2.3. AIDS
6.2.2.4. Others
6.2.3. Lifestyle Diseases
6.2.4. Genetic Diseases
6.2.5. Others
6.3. Global In-vitro Transcription Templates Market Attractiveness Analysis, by Disease

7. Global In-vitro Transcription Templates Market Analysis and Forecast, by Treatment
7.1. Introduction & Definition
7.1.1. Key Findings / Developments
7.2. Global In-vitro Transcription Templates Market Value Forecast, by Treatment, 2017-2031
7.2.1. Vaccine
7.2.2. Therapeutic
7.3. Global In-vitro Transcription Templates Market Attractiveness Analysis, by Treatment

8. Global In-vitro Transcription Templates Market Analysis and Forecast, by Research Stage
8.1. Introduction & Definition
8.1.1. Key Findings / Developments
8.2. Global In-vitro Transcription Templates Market Value Forecast by Research Stage, 2017-2031
8.2.1. Exploratory
8.2.2. Clinical
8.3. Global In-vitro Transcription Templates Market Attractiveness Analysis, by Research Stage

9. Global In-vitro Transcription Templates Market Analysis and Forecast, by End-user
9.1. Introduction & Definition
9.1.1. Key Findings / Developments
9.2. Global In-vitro Transcription Templates Market Value Forecast, by End-user, 2017-2031
9.2.1. Pharmaceutical & Biotechnology Companies
9.2.2. CROs & CMOs
9.2.3. Academics & Research
9.2.4. Others
9.3. Global In-vitro Transcription Templates Market Attractiveness Analysis, by End-user

10. Global In-vitro Transcription Templates Market Analysis and Forecast, by Region
10.1. Key Findings
10.2. Global In-vitro Transcription Templates Market Value Forecast, by Region
10.2.1. North America
10.2.2. Europe
10.2.3. Asia Pacific
10.2.4. Latin America
10.2.5. Middle East & Africa
10.3. Global In-vitro Transcription Templates Market Attractiveness Analysis, by Country/Region

11. North America In-vitro Transcription Templates Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. North America In-vitro Transcription Templates Market Value Forecast by Disease, 2017-2031
11.2.1. Cancer
11.2.1.1. Solid Tumors
11.2.1.2. Colorectal Cancer
11.2.1.3. NSCLC
11.2.1.4. Melanoma
11.2.1.5. Leukemia
11.2.1.6. Prostate Cancer
11.2.1.7. Others
11.2.2. Infectious Diseases
11.2.2.1. Influenza
11.2.2.2. COVID-19
11.2.2.3. AIDS
11.2.2.4. Others
11.2.3. Lifestyle Diseases
11.2.4. Genetic Diseases
11.2.5. Others
11.3. North America In-vitro Transcription Templates Market Value Forecast, by Treatment, 2017-2031
11.3.1. Vaccine
11.3.2. Therapeutic
11.4. North America In-vitro Transcription Templates Market Value Forecast, by Research Stage, 2017-2031
11.4.1. Exploratory
11.4.2. Clinical
11.5. North America In-vitro Transcription Templates Market Value Forecast, by End-user, 2017-2031
11.5.1. Pharmaceutical & Biotechnology Companies
11.5.2. CROs & CMOs
11.5.3. Academics & Research
11.5.4. Others
11.6. North America In-vitro Transcription Templates Market Value Forecast, by Country, 2017-2031
11.6.1. U.S.
11.6.2. Canada
11.7. North America In-vitro Transcription Templates Market Attractiveness Analysis
11.7.1. By Disease
11.7.2. By Treatment
11.7.3. By Research Stage
11.7.4. By End-user
11.7.5. By Country

12. Europe In-vitro Transcription Templates Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Europe In-vitro Transcription Templates Market Value Forecast, by Disease, 2017-2031
12.2.1. Cancer
12.2.1.1. Solid Tumors
12.2.1.2. Colorectal Cancer
12.2.1.3. NSCLC
12.2.1.4. Melanoma
12.2.1.5. Leukemia
12.2.1.6. Prostate Cancer
12.2.1.7. Others
12.2.2. Infectious Diseases
12.2.2.1. Influenza
12.2.2.2. COVID-19
12.2.2.3. AIDS
12.2.2.4. Others
12.2.3. Lifestyle Diseases
12.2.4. Genetic Diseases
12.2.5. Others
12.3. Europe In-vitro Transcription Templates Market Value Forecast, by Treatment, 2017-2031
12.3.1. Vaccine
12.3.2. Therapeutic
12.4. Europe In-vitro Transcription Templates Market Value Forecast, by Research Stage, 2017-2031
12.4.1. Exploratory
12.4.2. Clinical
12.5. Europe In-vitro Transcription Templates Market Value Forecast, by End-user, 2017-2031
12.5.1. Pharmaceutical & Biotechnology Companies
12.5.2. CROs & CMOs
12.5.3. Academics & Research
12.5.4. Others
12.6. Europe In-vitro Transcription Templates Market Value Forecast, by Country/Sub-region, 2017-2031
12.6.1. Germany
12.6.2. U.K.
12.6.3. France
12.6.4. Italy
12.6.5. Spain
12.6.6. Rest of Europe
12.7. Europe In-vitro Transcription Templates Market Attractiveness Analysis
12.7.1. By Disease
12.7.2. By Treatment
12.7.3. By Research Stage
12.7.4. By End-user
12.7.5. By Country/Sub-region

13. Asia Pacific In-vitro Transcription Templates Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Asia Pacific In-vitro Transcription Templates Market Value Forecast, by Disease, 2017-2031
13.2.1. Cancer
13.2.1.1. Solid Tumors
13.2.1.2. Colorectal Cancer
13.2.1.3. NSCLC
13.2.1.4. Melanoma
13.2.1.5. Leukemia
13.2.1.6. Prostate Cancer
13.2.1.7. Others
13.2.2. Infectious Diseases
13.2.2.1. Influenza
13.2.2.2. COVID-19
13.2.2.3. AIDS
13.2.2.4. Others
13.2.3. Lifestyle Diseases
13.2.4. Genetic Diseases
13.2.5. Others
13.3. Asia Pacific In-vitro Transcription Templates Market Value Forecast, by Treatment, 2017-2031
13.3.1. Vaccine
13.3.2. Therapeutic
13.4. Asia Pacific In-vitro Transcription Templates Market Value Forecast, by Research Stage, 2017-2031
13.4.1. Exploratory
13.4.2. Clinical
13.5. Asia Pacific In-vitro Transcription Templates Market Value Forecast, by End-user, 2017-2031
13.5.1. Pharmaceutical & Biotechnology Companies
13.5.2. CROs & CMOs
13.5.3. Academics & Research
13.5.4. Others
13.6. Asia Pacific In-vitro Transcription Templates Market Value Forecast, by Country/Sub-region, 2017-2031
13.6.1. Japan
13.6.2. China
13.6.3. India
13.6.4. Australia & New Zealand
13.6.5. Rest of Asia Pacific
13.7. Asia Pacific In-vitro Transcription Templates Market Attractiveness Analysis
13.7.1. By Disease
13.7.2. By Treatment
13.7.3. By Research Stage
13.7.4. By End-user
13.7.5. By Country/Sub-region

14. Latin America In-vitro Transcription Templates Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Latin America In-vitro Transcription Templates Market Value Forecast, by Disease, 2017-2031
14.2.1. Cancer
14.2.1.1. Solid Tumors
14.2.1.2. Colorectal Cancer
14.2.1.3. NSCLC
14.2.1.4. Melanoma
14.2.1.5. Leukemia
14.2.1.6. Prostate Cancer
14.2.1.7. Others
14.2.2. Infectious Diseases
14.2.2.1. Influenza
14.2.2.2. COVID-19
14.2.2.3. AIDS
14.2.2.4. Others
14.2.3. Lifestyle Diseases
14.2.4. Genetic Diseases
14.2.5. Others
14.3. Latin America In-vitro Transcription Templates Market Value Forecast, by Treatment, 2017-2031
14.3.1. Vaccine
14.3.2. Therapeutic
14.4. Latin America In-vitro Transcription Templates Market Value Forecast, by Research Stage, 2017-2031
14.4.1. Exploratory
14.4.2. Clinical
14.5. Latin America In-vitro Transcription Templates Market Value Forecast, by End-user, 2017-2031
14.5.1. Pharmaceutical & Biotechnology Companies
14.5.2. CROs & CMOs
14.5.3. Academics & Research
14.5.4. Others
14.6. Latin America In-vitro Transcription Templates Market Value Forecast, by Country/Sub-region, 2017-2031
14.6.1. Brazil
14.6.2. Mexico
14.6.3. Rest of Latin America
14.7. Latin America In-vitro Transcription Templates Market Attractiveness Analysis
14.7.1. By Disease
14.7.2. By Treatment
14.7.3. By Research Stage
14.7.4. By End-user
14.7.5. By Country/Sub-region

15. Middle East & Africa In-vitro Transcription Templates Market Analysis and Forecast
15.1. Introduction
15.1.1. Key Findings
15.2. Middle East & Africa In-vitro Transcription Templates Market Value Forecast, by Disease, 2017-2031
15.2.1. Cancer
15.2.1.1. Solid Tumors
15.2.1.2. Colorectal Cancer
15.2.1.3. NSCLC
15.2.1.4. Melanoma
15.2.1.5. Leukemia
15.2.1.6. Prostate Cancer
15.2.1.7. Others
15.2.2. Infectious Diseases
15.2.2.1. Influenza
15.2.2.2. COVID-19
15.2.2.3. AIDS
15.2.2.4. Others
15.2.3. Lifestyle Diseases
15.2.4. Genetic Diseases
15.2.5. Others
15.3. Middle East & Africa In-vitro Transcription Templates Market Value Forecast, by Treatment, 2017-2031
15.3.1. Vaccine
15.3.2. Therapeutic
15.4. Middle East & Africa In-vitro Transcription Templates Market Value Forecast, by Research Stage, 2017-2031
15.4.1. Exploratory
15.4.2. Clinical
15.5. Middle East & Africa In-vitro Transcription Templates Market Value Forecast, by End-user, 2017-2031
15.5.1. Pharmaceutical & Biotechnology Companies
15.5.2. CROs & CMOs
15.5.3. Academics & Research
15.5.4. Others
15.6. Middle East & Africa In-vitro Transcription Templates Market Value Forecast, by Country/Sub-region, 2017-2031
15.6.1. GCC Countries
15.6.2. South Africa
15.6.3. Rest of Middle East & Africa
15.7. Middle East & Africa In-vitro Transcription Templates Market Attractiveness Analysis
15.7.1. By Disease
15.7.2. By Treatment
15.7.3. By Research Stage
15.7.4. By End-user
15.7.5. By Country/Sub-region

16. Competition Landscape
16.1. Market Player - Competition Matrix (by tier and size of companies)
16.2. Market Share Analysis by Company, 2020
16.3. Company Profiles
16.3.1. Thermo Fisher Scientific, Inc.
16.3.1.1. Company Overview
16.3.1.2. Company Financials
16.3.1.3. Growth Strategies
16.3.1.4. SWOT Analysis
16.3.2. Promega Corporation
16.3.2.1. Company Overview
16.3.2.2. Growth Strategies
16.3.2.3. SWOT Analysis
16.3.3. Agilent Technologies, Inc.
16.3.3.1. Company Overview
16.3.3.2. Company Financials
16.3.3.3. Growth Strategies
16.3.3.4. SWOT Analysis
16.3.4. New England Biolabs
16.3.4.1. Company Overview
16.3.4.2. Growth Strategies
16.3.4.3. SWOT Analysis
16.3.5. Takara Bio Inc.
16.3.5.1. Company Overview
16.3.5.2. Company Financials
16.3.5.3. Growth Strategies
16.3.5.4. SWOT Analysis
16.3.6. Lucigen Corporation
16.3.6.1. Company Overview
16.3.6.2. SWOT Analysis
16.3.7. Enzynomics Co. Ltd.
16.3.7.1. Company Overview
16.3.7.2. SWOT Analysis
16.3.8. Enzo Life Sciences, Inc.
16.3.8.1. Company Overview
16.3.8.2. SWOT Analysis
16.3.9. Cytiva (Danaher)
16.3.9.1. Company Overview
16.3.9.2. Company Financials
16.3.9.3. Growth Strategies
16.3.9.4. SWOT Analysis

List of Tables
List of Table
Table 01: Global In-vitro Transcription Templates Market Value (US$ Mn) Forecast, by Disease, 2017-2031
Table 02: Global In-vitro Transcription Templates Market Value (US$ Mn) Forecast, by Cancer, 2017-2031
Table 03: Global In-vitro Transcription Templates Market Value (US$ Mn) Forecast, by Infectious Diseases, 2017-2031
Table 04: Global In-vitro Transcription Templates Market Value (US$ Mn) Forecast, by Treatment, 2017-2031
Table 05: Global In-vitro Transcription Templates Market Value (US$ Mn) Forecast, by Research Stage, 2017-2031
Table 06: Global In-vitro Transcription Templates Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 07: Global In-vitro Transcription Templates Market Value (US$ Mn) Forecast, by Region, 2017-2031
Table 08: North America In-vitro Transcription Templates Market Value (US$ Mn) Forecast, by Country, 2017-2031
Table 09: North America In-vitro Transcription Templates Market Value (US$ Mn) Forecast, by Disease, 2017-2031
Table 10: North America In-vitro Transcription Templates Market Value (US$ Mn) Forecast, by Cancer, 2017-2031
Table 11: North America In-vitro Transcription Templates Market Value (US$ Mn) Forecast, by Infectious diseases, 2017-2031
Table 12: North America In-vitro Transcription Templates Market Value (US$ Mn) Forecast, by Treatment, 2017-2031
Table 13: North America In-vitro Transcription Templates Market Value (US$ Mn) Forecast, by Research Stage, 2017-2031
Table 14: North America In-vitro Transcription Templates Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 15: Europe In-vitro Transcription Templates Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 16: Europe In-vitro Transcription Templates Market Value (US$ Mn) Forecast, by Disease, 2017-2031
Table 17: Europe In-vitro Transcription Templates Market Value (US$ Mn) Forecast, by Cancer, 2017-2031
Table 18: Europe In-vitro Transcription Templates Market Value (US$ Mn) Forecast, by Infectious diseases, 2017-2031
Table 19: Europe In-vitro Transcription Templates Market Value (US$ Mn) Forecast, by Treatment, 2017-2031
Table 20: Europe In-vitro Transcription Templates Market Value (US$ Mn) Forecast, by Research Stage, 2017-2031
Table 21: Europe In-vitro Transcription Templates Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 22: Asia Pacific In-vitro Transcription Templates Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 23: Asia Pacific In-vitro Transcription Templates Market Value (US$ Mn) Forecast, by Disease, 2017-2031
Table 24: Asia Pacific In-vitro Transcription Templates Market Value (US$ Mn) Forecast, by Cancer, 2017-2031
Table 25: Asia Pacific In-vitro Transcription Templates Market Value (US$ Mn) Forecast, by Infectious diseases, 2017-2031
Table 26: Asia Pacific In-vitro Transcription Templates Market Value (US$ Mn) Forecast, by Treatment, 2017-2031
Table 27: Asia Pacific In-vitro Transcription Templates Market Value (US$ Mn) Forecast, by Research Stage, 2017-2031
Table 28: Asia Pacific In-vitro Transcription Templates Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 29: Latin America In-vitro Transcription Templates Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 30: Latin America In-vitro Transcription Templates Market Value (US$ Mn) Forecast, by Disease, 2017-2031
Table 31: Latin America In-vitro Transcription Templates Market Value (US$ Mn) Forecast, by Cancer, 2017-2031
Table 32: Latin America In-vitro Transcription Templates Market Value (US$ Mn) Forecast, by Infectious diseases, 2017-2031
Table 33: Latin America In-vitro Transcription Templates Market Value (US$ Mn) Forecast, by Treatment, 2017-2031
Table 34: Latin America In-vitro Transcription Templates Market Value (US$ Mn) Forecast, by Research Stage, 2017-2031
Table 35: Latin America In-vitro Transcription Templates Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 36: Middle East & Africa In-vitro Transcription Templates Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 37: Middle East & Africa In-vitro Transcription Templates Market Value (US$ Mn) Forecast, by Disease, 2017-2031
Table 38: Middle East & Africa In-vitro Transcription Templates Market Value (US$ Mn) Forecast, by Cancer, 2017-2031
Table 39: Middle East & Africa In-vitro Transcription Templates Market Value (US$ Mn) Forecast, by Infectious Diseases, 2017-2031
Table 40: Middle East & Africa In-vitro Transcription Templates Market Value (US$ Mn) Forecast, by Treatment, 2017-2031
Table 41: Middle East & Africa In-vitro Transcription Templates Market Value (US$ Mn) Forecast, by Research Stage, 2017-2031
Table 42: Middle East & Africa In-vitro Transcription Templates Market Value (US$ Mn) Forecast, by End-user, 2017-2031

List of Figures
List of Figure
Figure 01: Global In-vitro Transcription Templates Market Value (US$ Mn) Forecast, 2017-2031
Figure 02: Global In-vitro Transcription Templates Market Value Share, by Disease, 2020
Figure 03: Global In-vitro Transcription Templates Market Value Share, by Extraction Type, 2020
Figure 04: Global In-vitro Transcription Templates Market Value Share, by Method, 2020
Figure 05: Global In-vitro Transcription Templates Market Value Share, by End-user, 2020
Figure 06: Global In-vitro Transcription Templates Market Value Share, by Region, 2020
Figure 07: Global In-vitro Transcription Templates Market Value Share Analysis, by Disease, 2020 and 2031
Figure 08: Global In-vitro Transcription Templates Market Attractiveness Analysis, by Disease, 2021-2031
Figure 09: Global In-vitro Transcription Templates Market Revenue (US$ Mn), by Cancer, 2017-2031
Figure 10: Global In-vitro Transcription Templates Market Revenue (US$ Mn), by Infectious Diseases, 2017-2031
Figure 11: Global In-vitro Transcription Templates Market Revenue (US$ Mn), by Lifestyle Diseases, 2017-2031
Figure 12: Global In-vitro Transcription Templates Market Revenue (US$ Mn), by Genetic Diseases, 2017-2031
Figure 13: Global In-vitro Transcription Templates Market Revenue (US$ Mn), by Others, 2017-2031
Figure 14: Global In-vitro Transcription Templates Market Value Share Analysis, by Treatment, 2020 and 2031
Figure 15: Global In-vitro Transcription Templates Market Attractiveness Analysis, by Treatment, 2021-2031
Figure 16: Global In-vitro Transcription Templates Market Revenue (US$ Mn), by Vaccine, 2017-2031
Figure 17: Global In-vitro Transcription Templates Market Revenue (US$ Mn), by Therapeutic, 2017-2031
Figure 18: Global In-vitro Transcription Templates Market Value Share Analysis, by Research Stage, 2020 and 2031
Figure 19: Global In-vitro Transcription Templates Market Attractiveness Analysis, by Research Stage, 2021-2031
Figure 20: Global In-vitro Transcription Templates Market Revenue (US$ Mn), by Exploratory, 2017-2031
Figure 21: Global In-vitro Transcription Templates Market Revenue (US$ Mn), by Clinical, 2017-2031
Figure 22: Global In-vitro Transcription Templates Market Value Share Analysis, by End-user, 2020 and 2031
Figure 23: Global In-vitro Transcription Templates Market Attractiveness Analysis, by End-user, 2021-2031
Figure 24: Global In-vitro Transcription Templates Market Revenue (US$ Mn), by Pharmaceutical & Biotechnology Companies, 2017-2031
Figure 25: Global In-vitro Transcription Templates Market Revenue (US$ Mn), by CROs & CMOs, 2017-2031
Figure 26: Global In-vitro Transcription Templates Market Revenue (US$ Mn), by Academics & Research, 2017-2031
Figure 27: Global In-vitro Transcription Templates Market Revenue (US$ Mn), by Others, 2017-2031
Figure 28: Global In-vitro Transcription Templates Market Value Share Analysis, by Region, 2020 and 2031
Figure 29: Global In-vitro Transcription Templates Market Attractiveness Analysis, by Region, 2021-2031
Figure 30: North America In-vitro Transcription Templates Market Value (US$ Mn) Forecast, 2017-2031
Figure 31: North America In-vitro Transcription Templates Market Value Share Analysis, by Country, 2020 and 2031
Figure 32: North America In-vitro Transcription Templates Market Attractiveness Analysis, by Country, 2021-2031
Figure 33: North America In-vitro Transcription Templates Market Value Share Analysis, by Disease, 2020 and 2031
Figure 34: North America In-vitro Transcription Templates Market Attractiveness Analysis, by Disease, 2021-2031
Figure 35: North America In-vitro Transcription Templates Market Value Share Analysis, by Treatment, 2020 and 2031
Figure 36: North America In-vitro Transcription Templates Market Attractiveness Analysis, by Treatment, 2021-2031
Figure 37: North America In-vitro Transcription Templates Market Value Share Analysis, by Research Stage, 2020 and 2031
Figure 38: North America In-vitro Transcription Templates Market Attractiveness Analysis, by Research Stage, 2021-2031
Figure 39: North America In-vitro Transcription Templates Market Value Share Analysis, by End-user, 2020 and 2031
Figure 40: North America In-vitro Transcription Templates Market Attractiveness Analysis, by End-user, 2021-2031
Figure 41: Europe In-vitro Transcription Templates Market Value (US$ Mn) Forecast, 2017-2031
Figure 42: Europe In-vitro Transcription Templates Market Value Share Analysis, by Country/Sub-region, 2020 and 2031
Figure 43: Europe In-vitro Transcription Templates Market Attractiveness Analysis, by Country/Sub-region, 2021-2031
Figure 44: Europe In-vitro Transcription Templates Market Value Share Analysis, by Disease, 2020 and 2031
Figure 45: Europe In-vitro Transcription Templates Market Attractiveness Analysis, by Disease, 2021-2031
Figure 46: Europe In-vitro Transcription Templates Market Value Share Analysis, by Treatment, 2020 and 2031
Figure 47: Europe In-vitro Transcription Templates Market Attractiveness Analysis, by Treatment, 2021-2031
Figure 48: Europe In-vitro Transcription Templates Market Value Share Analysis, by Research Stage, 2020 and 2031
Figure 49: Europe In-vitro Transcription Templates Market Attractiveness Analysis, by Research Stage, 2021-2031
Figure 50: Europe In-vitro Transcription Templates Market Value Share Analysis, by End-user, 2020 and 2031
Figure 51: Europe In-vitro Transcription Templates Market Attractiveness Analysis, by End-user, 2021-2031
Figure 52: Asia Pacific In-vitro Transcription Templates Market Value (US$ Mn) Forecast, 2017-2031
Figure 53: Asia Pacific In-vitro Transcription Templates Market Value Share Analysis, by Country/Sub-region, 2020 and 2031
Figure 54: Asia Pacific In-vitro Transcription Templates Market Attractiveness Analysis, by Country/Sub-region, 2021-2031
Figure 55: Asia Pacific In-vitro Transcription Templates Market Value Share Analysis, by Disease, 2020 and 2031
Figure 56: Asia Pacific In-vitro Transcription Templates Market Attractiveness Analysis, by Disease, 2021-2031
Figure 57: Asia Pacific In-vitro Transcription Templates Market Value Share Analysis, by Treatment, 2020 and 2031
Figure 58: Asia Pacific In-vitro Transcription Templates Market Attractiveness Analysis, by Treatment, 2021-2031
Figure 59: Asia Pacific In-vitro Transcription Templates Market Value Share Analysis, by Research Stage, 2020 and 2031
Figure 60: Asia Pacific In-vitro Transcription Templates Market Attractiveness Analysis, by Research Stage, 2021-2031
Figure 61: Asia Pacific In-vitro Transcription Templates Market Value Share Analysis, by End-user, 2020 and 2031
Figure 62: Asia Pacific In-vitro Transcription Templates Market Attractiveness Analysis, by End-user, 2021-2031
Figure 63: Latin America In-vitro Transcription Templates Market Value (US$ Mn) Forecast, 2017-2031
Figure 64: Latin America In-vitro Transcription Templates Market Value Share Analysis, by Country/Sub-region, 2020 and 2031
Figure 65: Latin America In-vitro Transcription Templates Market Attractiveness Analysis, by Country/Sub-region, 2021-2031
Figure 66: Latin America In-vitro Transcription Templates Market Value Share Analysis, by Disease, 2020 and 2031
Figure 67: Latin America In-vitro Transcription Templates Market Attractiveness Analysis, by Disease, 2021-2031
Figure 68: Latin America In-vitro Transcription Templates Market Value Share Analysis, by Treatment, 2020 and 2031
Figure 69: Latin America In-vitro Transcription Templates Market Attractiveness Analysis, by Treatment, 2021-2031
Figure 70: Latin America In-vitro Transcription Templates Market Value Share Analysis, by Research Stage, 2020 and 2031
Figure 71: Latin America In-vitro Transcription Templates Market Attractiveness Analysis, by Research Stage, 2021-2031
Figure 72: Latin America In-vitro Transcription Templates Market Value Share Analysis, by End-user, 2020 and 2031
Figure 73: Latin America In-vitro Transcription Templates Market Attractiveness Analysis, by End-user, 2021-2031
Figure 74: Middle East & Africa In-vitro Transcription Templates Market Value (US$ Mn) Forecast, 2017-2031
Figure 75: Middle East & Africa In-vitro Transcription Templates Market Value Share Analysis, by Country/Sub-region, 2020 and 2031
Figure 76: Middle East & Africa In-vitro Transcription Templates Market Attractiveness Analysis, by Country/Sub-region, 2021-2031
Figure 77: Middle East & Africa In-vitro Transcription Templates Market Value Share Analysis, by Disease, 2020 and 2031
Figure 78: Middle East & Africa In-vitro Transcription Templates Market Attractiveness Analysis, by Disease, 2021-2031
Figure 79: Middle East & Africa In-vitro Transcription Templates Market Value Share Analysis, by Treatment, 2020 and 2031
Figure 80: Middle East & Africa In-vitro Transcription Templates Market Attractiveness Analysis, by Treatment, 2021-2031
Figure 81: Middle East & Africa In-vitro Transcription Templates Market Value Share Analysis, by Research Stage, 2020 and 2031
Figure 82: Middle East & Africa In-vitro Transcription Templates Market Attractiveness Analysis, by Research Stage, 2021-2031
Figure 83: Middle East & Africa In-vitro Transcription Templates Market Value Share Analysis, by End-user, 2020 and 2031
Figure 84: Middle East & Africa In-vitro Transcription Templates Market Attractiveness Analysis, by End-user, 2021-2031
Note: Product cover images may vary from those shown
  • Thermo Fisher Scientific, Inc.
  • Promega Corporation
  • Agilent Technologies, Inc.
  • New England Biolabs
  • Takara Bio Inc.
  • Lucigen Corporation
  • Enzynomics Co. Ltd.
  • Enzo Life Sciences, Inc.
  • Cytiva (Danaher)
Note: Product cover images may vary from those shown
Adroll
adroll